Our group investigated the influence of single nucleotide polymorphisms (SNPs) in the promoter region of the ESR2 gene encoding ERβ on ovarian cancer risk in 184 ovarian cancer samples [84]. This evidence concerns the gene ESR2 and ovarian carcinoma.